Cargando…
Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma
Immunotherapy can improve the survival of patients with advanced lung squamous cell carcinoma (LUSC). T cytotoxic cells are one of the main members of the immune microenvironment. Herein, we aimed to identify the roles of T-cell cytotoxic markers interleukin 18 (IL18) receptor 1 (IL18R1) in the LUSC...
Autores principales: | Guo, Qiang, Wu, Chuang-Yan, Jiang, Ni, Tong, Song, Wan, Jun-Hao, Xiao, Xiao-Yue, Mei, Pei-Yuan, Liu, Hua-Song, Wang, Si-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760870/ https://www.ncbi.nlm.nih.gov/pubmed/36544782 http://dx.doi.org/10.3389/fimmu.2022.986447 |
Ejemplares similares
-
FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation
por: Liang, Xiaowei, et al.
Publicado: (2020) -
Prognosis of early stage small cell bladder cancer is not always dismal
por: Lim, Jun Hao, et al.
Publicado: (2019) -
Metastatic coagulopathic subdural hematoma: A dismal prognosis
por: George, Kuriakose J., et al.
Publicado: (2012) -
Primary Leiomyosarcoma of Breast Presenting with Metastasis: An Atypical Presentation with Dismal Prognosis
por: Singh, Garima, et al.
Publicado: (2017) -
Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer
por: Yang, Lingpeng, et al.
Publicado: (2020)